Global Hospital-acquired Urinary Tract Infection Testing Market 2016-2020

Table of Contents

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Market landscape

• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by technology

• Market overview
• Conventional method
• Imaging tests
• Point of care testing

PART 07: Market segmentation by product

• Market overview
• Assay kits and consumables
• Instruments

PART 08: Market segmentation by end-user

• Market overview
• Hospitals and outpatient department
• Diagnostic clinical laboratory

PART 09: Geographical segmentation

• Hospital-acquired urinary tract infection testing market in Americas
• Hospital-acquired urinary tract infection testing market in EMEA
• Hospital-acquired urinary tract infection testing market in APAC

PART 10: Market drivers

• Rising prevalence of hospital-acquired UTI increases patient volume
• Favorable reimbursements of urinary catheter increase catheter usage
• Focus on disease management
• Technological advances increase adoption rate of testing devices

PART 11: Impact of drivers

PART 12: Market challenges

• Growing preference over alternative products such as anti-infection catheters
• Stringent regulatory policies restrict new technologies to enter market
• Lack of healthcare infrastructure
• Lack of awareness of HAIs

PART 13: Impact of drivers and challenges

PART 14: Market trends

• Increased use of rapid diagnosis testing
• Increasing demand of infection control committee in hospitals
• Focus on early diagnosis

PART 15: Vendor landscape

• Competitive scenarios

PART 16: Key vendor analysis

• bioMerieux
• Roche Diagnostics
• Siemens Healthineer
• Other prominent vendors

PART 17: Appendix

• List of abbreviations

PART 18: Explore Technavio